339 related articles for article (PubMed ID: 34001847)
1. Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq.
He B; Liu S; Wang Y; Xu M; Cai W; Liu J; Bai W; Ye S; Ma Y; Hu H; Meng H; Sun T; Li Y; Luo H; Shi M; Du X; Zhao W; Chen S; Yang J; Zhu H; Jie Y; Yang Y; Guo D; Wang Q; Liu Y; Yan H; Wang M; Chen YQ
Signal Transduct Target Ther; 2021 May; 6(1):195. PubMed ID: 34001847
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
[TBL] [Abstract][Full Text] [Related]
4. Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection.
Zhang Y; Yan Q; Luo K; He P; Hou R; Zhao X; Wang Q; Yi H; Liang H; Deng Y; Hu F; Li F; Liu X; Feng Y; Li P; Qu L; Chen Z; Pan-Hammarström Q; Feng L; Niu X; Chen L
J Virol; 2022 Feb; 96(4):e0160021. PubMed ID: 34878902
[TBL] [Abstract][Full Text] [Related]
5. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.
Cao Y; Su B; Guo X; Sun W; Deng Y; Bao L; Zhu Q; Zhang X; Zheng Y; Geng C; Chai X; He R; Li X; Lv Q; Zhu H; Deng W; Xu Y; Wang Y; Qiao L; Tan Y; Song L; Wang G; Du X; Gao N; Liu J; Xiao J; Su XD; Du Z; Feng Y; Qin C; Qin C; Jin R; Xie XS
Cell; 2020 Jul; 182(1):73-84.e16. PubMed ID: 32425270
[TBL] [Abstract][Full Text] [Related]
6. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
Newell KL; Clemmer DC; Cox JB; Kayode YI; Zoccoli-Rodriguez V; Taylor HE; Endy TP; Wilmore JR; Winslow GM
PLoS One; 2021; 16(1):e0244855. PubMed ID: 33507994
[TBL] [Abstract][Full Text] [Related]
7. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
Hartley GE; Edwards ESJ; Aui PM; Varese N; Stojanovic S; McMahon J; Peleg AY; Boo I; Drummer HE; Hogarth PM; O'Hehir RE; van Zelm MC
Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33443036
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
Andreano E; Piccini G; Licastro D; Casalino L; Johnson NV; Paciello I; Dal Monego S; Pantano E; Manganaro N; Manenti A; Manna R; Casa E; Hyseni I; Benincasa L; Montomoli E; Amaro RE; McLellan JS; Rappuoli R
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34417349
[TBL] [Abstract][Full Text] [Related]
9. Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing.
Jin X; Zhou W; Luo M; Wang P; Xu Z; Ma K; Cao H; Xu C; Huang Y; Cheng R; Xiao L; Lin X; Pang F; Li Y; Nie H; Jiang Q
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34015809
[TBL] [Abstract][Full Text] [Related]
10. Stereotypic neutralizing V
Kim SI; Noh J; Kim S; Choi Y; Yoo DK; Lee Y; Lee H; Jung J; Kang CK; Song KH; Choe PG; Kim HB; Kim ES; Kim NJ; Seong MW; Park WB; Oh MD; Kwon S; Chung J
Sci Transl Med; 2021 Jan; 13(578):. PubMed ID: 33397677
[TBL] [Abstract][Full Text] [Related]
11. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
[TBL] [Abstract][Full Text] [Related]
12. Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2.
Xie J; Ding C; He J; Zhang Y; Ni S; Zhang X; Chen Q; Wang J; Huang L; He H; Li W; Ma H; Jin T; Zhang S; Gao Y
Front Immunol; 2021; 12():715464. PubMed ID: 34539645
[TBL] [Abstract][Full Text] [Related]
13. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
Bieberich F; Vazquez-Lombardi R; Yermanos A; Ehling RA; Mason DM; Wagner B; Kapetanovic E; Di Roberto RB; Weber CR; Savic M; Rudolf F; Reddy ST
Front Immunol; 2021; 12():701085. PubMed ID: 34322127
[TBL] [Abstract][Full Text] [Related]
14. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
Notarbartolo S; Ranzani V; Bandera A; Gruarin P; Bevilacqua V; Putignano AR; Gobbini A; Galeota E; Manara C; Bombaci M; Pesce E; Zagato E; Favalli A; Sarnicola ML; Curti S; Crosti M; Martinovic M; Fabbris T; Marini F; Donnici L; Lorenzo M; Mancino M; Ungaro R; Lombardi A; Mangioni D; Muscatello A; Aliberti S; Blasi F; De Feo T; Prati D; Manganaro L; Granucci F; Lanzavecchia A; De Francesco R; Gori A; Grifantini R; Abrignani S
Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34376481
[TBL] [Abstract][Full Text] [Related]
15. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques.
Marlin R; Godot V; Cardinaud S; Galhaut M; Coleon S; Zurawski S; Dereuddre-Bosquet N; Cavarelli M; Gallouët AS; Maisonnasse P; Dupaty L; Fenwick C; Naninck T; Lemaitre J; Gomez-Pacheco M; Kahlaoui N; Contreras V; Relouzat F; Fang RHT; Wang Z; Ellis J; Chapon C; Centlivre M; Wiedemann A; Lacabaratz C; Surenaud M; Szurgot I; Liljeström P; Planas D; Bruel T; Schwartz O; Werf SV; Pantaleo G; Prague M; Thiébaut R; Zurawski G; Lévy Y; Grand RL
Nat Commun; 2021 Sep; 12(1):5215. PubMed ID: 34471122
[TBL] [Abstract][Full Text] [Related]
16. Pregnant Women Develop a Specific Immunological Long-Lived Memory Against SARS-COV-2.
Fenizia C; Cetin I; Mileto D; Vanetti C; Saulle I; Di Giminiani M; Saresella M; Parisi F; Trabattoni D; Clerici M; Biasin M; Savasi V
Front Immunol; 2022; 13():827889. PubMed ID: 35251011
[TBL] [Abstract][Full Text] [Related]
17. Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.
Moriyama S; Adachi Y; Sato T; Tonouchi K; Sun L; Fukushi S; Yamada S; Kinoshita H; Nojima K; Kanno T; Tobiume M; Ishijima K; Kuroda Y; Park ES; Onodera T; Matsumura T; Takano T; Terahara K; Isogawa M; Nishiyama A; Kawana-Tachikawa A; Shinkai M; Tachikawa N; Nakamura S; Okai T; Okuma K; Matano T; Fujimoto T; Maeda K; Ohnishi M; Wakita T; Suzuki T; Takahashi Y
Immunity; 2021 Aug; 54(8):1841-1852.e4. PubMed ID: 34246326
[TBL] [Abstract][Full Text] [Related]
18. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.
Jeong H; Choi YM; Seo H; Kim BJ
Front Immunol; 2021; 12():637654. PubMed ID: 33732258
[TBL] [Abstract][Full Text] [Related]
19. Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.
Yan Q; He P; Huang X; Luo K; Zhang Y; Yi H; Wang Q; Li F; Hou R; Fan X; Li P; Liu X; Liang H; Deng Y; Chen Z; Chen Y; Mo X; Feng L; Xiong X; Li S; Han J; Qu L; Niu X; Chen L
Emerg Microbes Infect; 2021 Dec; 10(1):1097-1111. PubMed ID: 33944697
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display.
Ehling RA; Weber CR; Mason DM; Friedensohn S; Wagner B; Bieberich F; Kapetanovic E; Vazquez-Lombardi R; Di Roberto RB; Hong KL; Wagner C; Pataia M; Overath MD; Sheward DJ; Murrell B; Yermanos A; Cuny AP; Savic M; Rudolf F; Reddy ST
Cell Rep; 2022 Jan; 38(3):110242. PubMed ID: 34998467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
